| Trial ID: | L0487 |
| Source ID: | ChiCTR1800019570
|
| Associated Drug: |
TQA3526
|
| Title: |
Evaluation of TQA3526 single-center, randomized, double-blind, placebo-controlled, multi-dose, single-, multiple-dose, and pharmacokinetic Phase Ia clinical trial in healthy subjects
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
1 Primary Biliary Cholangitis, PBC, 2 NASH
|
| Interventions: |
Group 1:The first group (pre-test) 2 subjects, 2 patients received the test drug, 1 case for male and female, once administered, administered under fasting conditions, and evaluated for tolerance at D2 and D4. The next set of tests was performed on the pr
|
| Outcome Measures: |
plasma concentration;ALP;Fibroblast growth factor;FGF-19;BA precursor C4 (7a-hydroxy-cholest-4-ene-3-one);Serum cholesterol;bile acid;nan
|
| Sponsor/Collaborators: |
The First Hospital of Jilin University
|
| Gender: |
All
|
| Age: |
1855
|
| Phases: |
Phase 1
|
| Enrollment: |
Group 1:2;Group 2:10;Group 3:10;Group 4:10;Group 5:10;Group 6:10;Group 7:10;Group 3 or Group 4 or Group 5:18;Group 4 or Group 5 or Group 6:10;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
18/11/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 November 2018
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=32944
|
